ITH rare exceptions, tumors of the glomus jugulare are benign, slow-growing paragangliomas. Since the first documentation of removal of this type of lesion by Rosenwasser in 1945, 51 these tumors continue to present a treatment challenge accompanied by marked controversy. As recently as 1978, Simko and colleagues 57 stated that complete surgical excision of these lesions is seldom possible because of their vascularity, invasive character, and critical location, and often because of the advanced stage of the tumor at presentation. Nevertheless, advances in neuroimaging, skull base techniques, embolization, anesthesia, and emphasis on postoperative care have markedly improved the surgeon's ability to remove these tumors and have improved outcome in an overwhelming number of patients with tumors of the glomus jugulare. 20, 23, 25, 65 Studies with long-term follow up show the effectiveness of total removal in achieving a cure. 22, 40, 49 There remains, however, a subgroup of glomus jugulare tumors that is rarely encountered and seldom reported, although these tumors continue to present a formidable challenge to treatment. We classified this group under the term "complex glomus jugulare tumors." These tumors are frequently considered extremely high risk or inoperable. 11, 20, 31, 58 To qualify for this category, one or more of the following criteria must be met: giant size, multiple paragangliomas (bilateral or ipsilateral), malignancy, catecholamine secretion, association with other lesions such as a dural arteriovenous malformation or an adrenal tumor, or previous treat-
ment with adverse outcome that makes surgical intervention a much higher risk, such as sacrifice of the CA, radiation therapy, and postoperative deficits or adverse effects from embolization.
Clinical Material and Methods
We reviewed a database of patients with pathological conditions of the skull base treated by the senior author to identify those patients with complex glomus jugulare tumors. Forty-three patients fulfilled one or more of the criteria for these tumors: 38 patients harbored giant tumors, 11 had multiple paragangliomas (bilateral in seven cases and ipsilateral in four cases), two had tumors with hypersecretion of catecholamine, one had a malignant paraganglioma, six had associated lesions, and 19 had undergone previous treatments with adverse outcomes (surgical, radiation, or embolization) that increased the surgical risk because neurovascular structures had been compromised ( Table 1) . Tumors of the glomus jugulare that did not meet the criteria of complex tumors were excluded because their treatment and outcomes have been well described in the literature. The patients in our series were treated between July 1982 and June 2001 at four institutions: King Faisal Specialist Hospital in Riyadh, Saudi Arabia; the University of Mississippi Medical Center; Loyola University Medical Center in Chicago; and the University of Arkansas for Medical Sciences. A few of the patients have been included in previous case reports or descriptions of surgical technique. 2, 5, 8 The medical record (hospital, clinic, department, and follow-up notes) of each patient was reviewed. Twenty-eight patients underwent surgical treatment. The remaining patients either declined surgery and received radiation therapy at other institutions or were followed up conservatively. Patients were evaluated through detailed neurological, neuroophthalmological, and neurootological examinations. High-resolution CT scans of the temporal bone with a bone algorithm were obtained. Multiplanar MR images were obtained both with and without contrast enhancement (nine patients were treated before MR imaging was available). In each patient the serum catecholamine level was measured routinely, as were urine levels of vanillylmandelic acid and metanephrines. Computerized tomography scans of the abdomen were obtained to look for associated adrenal lesions. The vascular anatomy and the blood supply were delineated through cerebral angiography, and cerebral collateral blood flow was assessed through cross-compression studies. Only two patients underwent a balloon occlusion test. In 20 patients, superselective tumor embolization was performed using polyvinyl alcohol, which was injected through the branches of the external CA prior to surgery. Follow-up CT scans were obtained immediately after surgery. Postoperatively, MR images were acquired early after surgery; follow-up images were obtained at 6-month intervals for the 1st year and later on an annual basis. The follow-up period was defined as the period extending from surgery to the most recent clinical visit or patient contact (mean 38 months, range 2-108 months).
Results
Among these 43 patients were 32 female and 11 male patients ranging in age from 11 to 86 years (mean 47 years). All but one patient presented with neurological deficits. Clinical findings are presented in Table 2 . Cranial nerve deficits, particularly those associated with the lower cranial nerves, were the prominent feature (Table 3) .
All tumors were clearly identified on the imaging studies. The CT, MR imaging, and angiographic findings were diagnostic for paragangliomas. Multiple tumors were also depicted on MR imaging studies, except for one small sphenopalatine paraganglioma that was seen only on an angiogram. Angiographic studies were critical for assessing the appropriateness of preoperative embolization after the tumor's blood supply had been demonstrated. The most critical aspect of the angiographic evaluation in patients who had undergone previous embolization or CA occlusion was the identification of new feeding vessels from the ICA and vertebrobasilar artery circulation.
Surgical Considerations
Twenty-eight patients underwent resection in an attempt at total tumor removal. Gross-total removal was determined intraoperatively and confirmed by postoperative MR images in 24 patients. Four patients harbored small residual tumors. The surgical approach was tailored according to the patient's anatomy, condition, and deficits (Table 4) . Transposition of the facial nerve was avoided in all patients with bilateral lesions and was necessary in only five cases. Three technical maneuvers deserve particular emphasis and are described in the following subsections. Intrabulbar Dissection. Intrabulbar dissection is a maneuver that facilitates preservation of the lower cranial nerves. This maneuver can be used for any tumor, as long as the tumor itself has not penetrated the wall of the jugular bulb or actually infiltrated the cranial nerves.
A skull base approach that skeletonized the sigmoid sinus, jugular bulb, and facial nerve was used. After the upper neck had been dissected and the ninth through 12th nerves had been exposed along the JV, the sigmoid sinus was ligated distally and the JV was ligated proximally. The outer wall of the lower sigmoid sinus was incised along the jugular bulb into the JV. The tumor was then removed from inside the jugular bulb and the sigmoid sinus, and the tail end of the JV was separated from the lower cranial nerves (Fig.  1) . The innermost venous wall separating the tumor from the nerves was left in situ to minimize dissection, traumatization, manipulation, or devascularization of the lower cranial nerves. We used this procedure in the last 11 cases. Using this technique, we were able to preserve the immediate postoperative function of the lower cranial nerves in four patients in whom the tumor did not transgress the venous wall at the jugular foramen.
Isolation of Giant Tumors. Each tumor was totally isolated for safe surgical removal. This is best done in one stage through the combined posterior fossa and infratemporal approach. 2 This approach allows the tumor to be devascularized from the intrapetrous CA. It also is used to separate the tumor from the posterior fossa and dissect the lower portion from the nerves with minimal blood loss while preserving the vessels (Fig. 2) .
Arterial and Venous Handling. Resection of tumors of the glomus jugulare requires special techniques in the handling of both arterial and venous dissection. Although paragangliomas engulf, adhere to, and receive blood from the ICA, with the aid of the operating microscope, we have been able to identify a plane of dissection to separate the tumor from the CA; thus, we found it unnecessary to sacrifice the CA or to reconstruct it. Only one patient had severe delayed vasospasm with thrombosis of the CA that required endovascular injection of urokinase.
Because exposure of tumors of the glomus jugulare requires neck dissection, associated tumors of the carotid body can be removed at the same time without additional morbidity or undue lengthening of the operating time.
Glomus jugulare tumors often shunt blood with high venous outflow. Accordingly, they should be handled as arteriovenous malformations. Therefore, venous drainage from the tumor should be preserved and the proximal end of the JV unligated until the tumor is isolated and its arterial supply is devascularized. We had to reestablish venous flow by using a shunt tube after premature ligation and sectioning of the JV, which caused profuse bleeding from the tumor.
Outcome of Surgically Treated Patients
There was no instance of operative mortality in our series of patients, and gross-total removal was achieved in 24 of the 28 surgically treated patients. Immediate postoperative complications included one case of pneumothorax, one case of pulmonary embolism, and four cases of cerebrospinal fluid leak, which were treated through spinal drainage. In five patients infection developed at the closed external ear canal. Two of these infections progressed to osteomyelitis of the temporal bone; in one of these cases surgical debridement was required and the patient experienced meningitis. All infections were treated successfully. One patient had a retroperitoneal hematoma of undetermined cause that developed postoperatively. Another patient experienced hemiplegia postoperatively due to CA thrombosis, but recovered after endovascular injection of urokinase. One patient expe-
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Complex glomus jugulare tumors 1359 Table 5 . Five patients required a tracheostomy and four needed a gastrostomy. Two tumors recurred, one tumor that was malignant (see Case 2) and one benign tumor that recurred after 5 years. The average follow-up period of 38 months in this series is, unfortunately, relatively short. Many patients were lost to long-term follow up because they underwent surgery in various hospitals and we were not able to obtain continuous evaluations.
Illustrative Cases

Case 1
This 36-year-old woman presented with symptoms of hoarseness, neck pain, headache, and hypertension. On examination, she had decreased sensation in the first and second divisions of the fifth cranial nerve and palsies of the ninth and 10th nerves on the right side. Radiological studies demonstrated the presence of five paragangliomas: a glomus jugulare tumor on the right side, a glomus tympanicum tumor on the left side, bilateral carotid body tumors, and a sphenopalatine fossa tumor on the left side (Fig. 3) .
Findings of an endocrinological workup in which a clonidine suppression test had been performed were positive for catecholamine secretion. The patient underwent resection of the tumors of the right glomus jugulare and the carotid body in the same setting. A tracheotomy tube, which had been placed preoperatively, was removed within 1 week, and the patient experienced transient facial nerve weakness on the right side from which she fully recovered. The facial nerve was deliberately not mobilized to minimize the risk of postoperative deficits. The ear canal was not closed to prevent the chance of hearing loss.
Two-and-a-half years later this patient underwent angiographic studies, which demonstrated marked enlargement of the carotid body tumor on the left side. She underwent resection of this tumor during which every attempt was made to preserve the lower cranial nerves and the facial nerve. Postoperatively, there was only a minor increase in secretions, and she was able to be discharged with a special diet. The problem intensified later, however, and required insertion of a tracheostomy tube and creation of a jejunostomy as well as eventual laryngeal reconstruction.
This case demonstrates the difficulty in treating multicentric paragangliomas. Patients with these tumors are at risk for bilateral morbid cranial nerve deficits (those of the seventh, eighth, or lower cranial nerves). Any of these occurrences decreases the patient's quality of life; therefore, appropriate management should be considered in advance and surgery or treatment should not be undertaken unless the tumor becomes fairly symptomatic and causes deficits or demonstrates clear growth. For surgical treatment, the surgeon should modify the technique to minimize the risk of bilateral deficits. These modifications include avoiding mobilization of the facial nerve, abandoning blind-sac closure of the external ear canal (associated with the infratemporal approach), performing intrabulbar dissection to prevent injury to the lower cranial nerves, accepting partial removal in an attempt to preserve lower cranial nerve function, and considering radiosurgery for the tumor on the opposite side, if treatment becomes necessary.
Case 2
This 55-year-old man underwent radiation therapy in 1976 after a biopsy confirmed a glomus tympanicum tumor in his left middle ear. He received 50 Gy in 15 fractions in a single field from the left side. In 1987, a right nephrectomy was performed for renal cell carcinoma. In 1997, the patient underwent embolization and a biopsy for a recurrent paraganglioma that caused lower cranial nerve deficits and facial nerve palsy. The facial nerve palsy progressed and diplopia developed. Because the tumor was enormous and had previously been treated with radiotherapy, it was considered inoperable and a trial of hydroxyurea was carried out with no response. When the patient presented to our institution, he had deficits in the fifth through 11th cranial nerves and paralysis of the 12th nerve with positive cerebellar signs. At the time the patient was receiving anticoagulation therapy for deep vein thrombosis. As part of the workup, he underwent a carotid balloon occlusion test to evaluate the collateral blood supply. The test caused ischemic deficits that took 2 months to resolve. The patient then underwent a total petrosectomy followed by total resection of the tumor. Postoperatively, he did well with no change in the earlier neurological findings. Immunohistochemical analysis confirmed a paraganglioma that stained positively for chromogranin with granules in the cytoplasm of cells, and chromosomal analysis demonstrated a nonclonal translocation that appeared randomly. Four months later, a large, rapidly growing recurrence of tumor became apparent, causing the patient's death (Fig. 4) .
This case demonstrates the extensive neurological deficits that giant paragangliomas inflict. The surgical challenge lies in treating a giant tumor that involves the whole skull base and totally encases the CA. On the other hand, there is the ability to remove the tumor. The aggressive nature of the tumor recurrence defied any surgical excision and the case took an extremely malignant course. There is the question of whether administering radiation was effective for treating the small glomus tympanicum tumor in the ear 15 years earlier. This treatment may have been a factor in the aggressive transformation of this tumor into a malignant lesion. Radionecrosis of the temporal bone was also present on pathological findings in 1997. 
Case 3
In 1983, a 41-year-old man underwent partial resection of a tumor of the glomus jugulare. In 1991, he underwent a second surgery for a large recurrence of the tumor. The second operation was complicated by an intraoperative crisis in blood pressure, prolonged hospitalization with multiple cranial nerve deficits, pneumonia, aspiration, a cerebrospinal fluid leak, local tissue ischemia, and deep vein thrombosis. The patient was referred to us because his condition continued to deteriorate, he demonstrated metabolic wasting, and there was difficulty in managing his hypertension. When he presented to us in 1992, he had cranial nerve paralysis from the seventh to the 12th nerve on the left side. Imaging studies demonstrated a gigantic tumor that compressed the brainstem and posterior fossa, extended into the petrous canal and the cavernous sinus, and developed new vascularization from the opposite CA and vertebral artery after previous occlusion of the CA and embolization (Fig.  5) . The patient underwent total removal of his tumor after preparation with a combined alpha and beta blocker. The tumor resection was followed by reconstruction with a free muscle flap. Pathological investigation confirmed the presence of a catecholamine-secreting tumor. The patient had a transient ocular motor dysfunction from which he recovered, but the cranial nerve deficits that appeared earlier remained unchanged. He has had no recurrence as of the 7-year follow-up review.
This case shows the combination of factors that constitute a complex tumor of the glomus jugulare and presents the challenges of treating giant tumors, particularly those with catecholamine hypersecretion, brainstem compression, morbid deficits, and prior surgical, neurological, and systemic complications. This case emphasizes that current multidisciplinary advances have made the surgical treatment of such formidable lesions feasible and successful.
Discussion
Giant Tumors
The advent of computerized imaging, selective embolization, new surgical approaches, refinement of surgical techniques, and increased expertise have made it possible to treat glomus tympanicum and glomus jugulare tumors of moderate size surgically with good results and long-term disease control. 23, 33, 40, 49 In 1969, McCabe and Fletcher 42 advocated the concept that the size and extent of the tumor are decisive for selecting the most appropriate form of therapy. Hence, authors of subsequent studies classified these tumors, emphasizing their size and intracranial extensions, 20, 28 and the operability of each tumor was decided by these factors. Still, it was wishful thinking that very large tumors could be removed.
Giant tumors are encountered rarely and are usually considered inoperable 20, 58 or are associated with high rates of morbidity and mortality. 13, 31, 47, 58 The two established classifications of these tumors are based mainly on tumor size with special emphasis on intracranial extension as a decisive factor for resectability. 20, 27 For example, Type D2 in the classification of Fisch and colleagues 20 constitutes a tumor with an intracranial extension larger than 2 cm in diameter that mandates a two-stage surgery, and type D3 tumors are considered inoperable.
Similarly, in the classification of Glasscock and Jackson, 28 a glomus jugulare tumor of Type IV extends beyond the petrous apex into the clivus or infratemporal fossa and may have an intracranial extension. Patel, et al., 47 have voiced reservations about size alone being the critical factor and proposed that brainstem compression and vascular encasement should be considered because they can indicate higher complications and are, therefore, of prognostic value. The classification of Alford and Guilford 1 defines a Stage IV tumor as one that has spread beyond the temporal bone, as indicated by the presence of multiple cranial nerve involvement. 11 All these classifications distinguish a group of complex tumors that present challenges to treatment and are associated with adverse outcomes. Brown 11 treated 42 Stage IV tumors, but never used surgery alone. Nineteen of the patients did not even undergo surgery, and another 19 underwent both surgery and radiotherapy.
The natural history of this tumor is generally believed to be benign and it may take years for adverse effects to appear. Unfortunately, the course of large tumors that cause neurological deficits is different. Thirty-five percent of patients in the series reported by Brown 11 died within the 10-year follow-up period.
Twenty-eight of our surgically treated patients harbored lesions that fulfilled the criteria for a giant tumor, and most of these tumors had a large intracranial, intradural extension that compressed the brainstem and extended into the petrous bone, the clivus, and the foramen magnum. Although surgery was lengthy, gross-total resection was feasible in the majority of patients without death or significant morbidity. We believe the key to resection is the total isolation of the tumor through a combined approach that exposes both the extracranial and intracranial extensions of the lesion.
2,23,47 Thus, we hold in disfavor the staging of surgery to tackle the extradural and intradural portions of the tumor separately.
Multiple Paragangliomas
Multiple paragangliomas present the greatest challenge to treating complex paragangliomas because the treatment decision is not made based on a single tumor, but on the quality and length of the patient's life. Whether to treat, when to treat, which tumors to treat, with which modality (surgery or radiation) of treatment, and in which sequence-all are questions that must be addressed at the first evaluation and thoroughly considered throughout the patient's follow up. The surgeon must try to prevent the consequences of multiple bilateral cranial nerve deficits, that is, severe morbidity and a poor quality of life.
Multicentricity associated with glomus tumors is reported to be more than 10%. 23, 31, 58, 65 Familial cases, most of which have involved fathers and daughters, have a much higher incidence of multicentricity, up to 55%. 62, 64 The rate of multicentricity in our patients was 34.5%, but none of our patients had the familial form of the disease. The possibility of multicentricity, which is significant in number and extremely high in cases of the familial form, mandates that each patient who is given a diagnosis of paraganglioma in one location must be fully evaluated for other lesions. Most multicentric tumors, however, are bilateral tumors of the carotid body. 44, 48 The second lesion associated with a tumor of the glomus jugulare is usually a tumor of the ipsilateral carotid body. Because this tumor is also exposed during the approach to the glomus jugulare tumor, and the lower cranial nerves on that side are dissected at the lower pole of the glomus jugulare tumor, we believe that a unilateral carotid body tumor is best excised during the same operation.
A few cases of bilateral glomus jugulare tumors associated with carotid body tumors have been reported. [62] [63] [64] [65] These cases illustrate the paramount need for accurate evaluation, including family evaluation and counseling. Because of the high morbidity associated with deficits of the bilateral seventh nerve, the eighth nerve, and the lower cranial nerves, and the poor quality of life projected for any patient having these deficits, either from the tumor or as a consequence of treatment, the bilateral form of these tumors requires the most thoughtful and thorough evaluation and counseling with clear patient expectations. We agree with the recommendations of Van Der Mey and colleagues 64 that the opposite side should be treated surgically only if the first resection did not cause essential cranial nerve palsy. Otherwise, these authors refrain from surgery and favor close follow-up review. Unfortunately, our patient who experienced a rapid growth that prompted surgery on the opposite side for a carotid body tumor had prolonged dysfunction of swallowing and pulmonary complications.
For patients with multiple paragangliomas, the surgical technique should also be modified. The classic infratemporal approach of Fisch and colleagues, 19, 20 which includes facial nerve transposition, blind-sac closure of the ear canal, and subsequent loss of air conduction hearing, should be modified to minimize the risk of facial nerve palsy and, at least, conductive hearing loss. 2 Intrabulbar dissection is particularly critical in these cases to maximize the chance of preserving lower cranial nerves on the operated side so that one could, in the future, treat the opposite side. The surgeon must also consider the role of radiosurgery for bilateral tumors. Radiation therapy has long been used to treat glomus tumors, particularly those that are partially removed or have recurred. 14, 15, 52 Glomus tumors are known to be radioresistant, however, and the effect of radiation is often the induction of fibrosis, mainly along the vessels supplying the tumors. 12, 24 In addition, persistent viable tumors are often present long after radiotherapy. Radiation therapy has also been associated with long-term side effects that include temporal bone osteonecrosis, development of a new malignancy, and brain injury. 14, 37 Early reports of stereotactic radiosurgery for glomus tumors are encouraging. 17, 21, 36, 39 It appears to be very effective if the target size is within the optimal size for radiosurgery. All our patients harbored tumors that were too large for this treatment. The preliminary results of radiosurgery suggest a symptomatic improvement of cranial nerve function. 39 If radiosurgery is proven to be effective with few complications from cranial nerve deficits, it will be a great complement to the treatment of bilateral glomus jugulare tumors and residual tumors left after resection of giant tumors. The concern over the high level of morbidity associated with multiple cranial nerve deficits and the capability of radiosurgery to treat unresectable residual tumor have led to the recommendation of this treatment modality for petroclival meningiomas. 15 
Cranial Nerve Deficits
Surgery of tumors of the glomus jugulare has been haunted by the complication of postoperative deficits of the lower and other cranial nerves. 13, 29, 30, 64, 65 Although this finding has been exploited by the proponents of radiation therapy, 10, 16, 60 in patients with giant tumors the lower cranial nerves are already seriously affected. Patients may require additional pulmonary cautions during the early postoperative weeks to avoid aspiration. We believe, however, that intrabulbar dissection can help preserve the function of the lower cranial nerves. Unfortunately, this technique is not useful for tumors that penetrate the outer layer of the venous wall or that actually invade the cranial nerves.
40,55
Vascular Considerations
The literature contains many statements with regard to tumor invasion of the arterial wall and sacrifice of the CA either in advance or intraoperatively. Reports also document particular difficulties encountered in treating the petrous carotid segment. 4, 31 Sacrifice and reconstruction of the CA, however, have both been associated with major risks. 20, 64 Two patients in the series of Jackson and colleagues 31 suffered intraoperative trauma to the ICA, which was associated with massive stroke and subsequent death. We believe, however, that a controlled ICA dissection can be performed. A plane can be developed between the adventitia and the tumor and, with the aid of the microscope, the feeding vessel from the CA can be coagulated and sectioned. We do not believe that deliberate sacrifice of the CA is warranted. The risk of permanent CA occlusion is high, even in patients who pass a balloon occlusion test. 28, 45 Our experience in this series reinforces our previous commitment to preserving the CA. 3, 9, 45 The balloon occlusion test itself carries a complication rate of 3.7%. 61 Similarly, revascularization with a bypass carries the risk of ischemic complications. 54, 56, 59 Previous occlusion or embolization of the CA creates a new blood supply from the vertebral artery and the internal petrous CA, which increases the risk of arterial dissection.
There has been little discussion about managing venous outflow. In this respect, tumors of the glomus jugulare must be considered to be arteriovenous malformations. A considerable amount of blood is shunted through the collateral venous plexus, particularly if the sigmoid sinus is totally occluded. Ligation of the JV must be delayed until the end of the procedure to maintain good venous drainage from the tumor and to achieve full devascularization from the arterial side and the surrounding area before the final interruption of blood drainage.
Hormone-Secreting Paragangliomas
Paragangliomas are sometimes associated with the secretion of a wide variety of neuropeptide hormones, including adrenocorticotropic hormone, serotonin, catecholamine, and dopamine. Thus far the focus has been on the secretion of norepinephrine. 6, 34, 41, 43 The incidence of catecholamine secretion is approximately 4%. 11, 32 Frequently, these tumors have a low level of secretion that is not recognized clinically. 43 Because of the potentially serious complications of an intra-or perioperative hypertension crisis, we agree that screening for excess catecholamine secretion is indicated in all patients with tumors of the glomus jugulare. 28, 43, 53 In patients with catecholamine secretion and multicentric tumors, selective intravenous sampling is warranted to establish the site of catecholamine production. 46 The actual treatment and the duration of prophylaxis depends on the level of catecholamine secretion and its source. Patients with these tumors might also harbor adrenal norepinephrine-secreting tumors. Thus, adrenal imaging is particularly important in patients with hypersecreting tumors. Patients with confirmed hypersecreting tumors (patients in whom the catecholamine level is four times higher than normal) require preparation with an alpha and beta catecholamine blocker such as labetalol before surgery, angiography, or embolization. Beta blockers should not be used before alpha blockers. An unopposed alpha agonist introduced into the setting of a beta blocker can cause severe hypertension and cardiac crisis. 34 Recently, calcium-channel blockers and magnesium sulfate were recommended for patients with pheochromocytoma. 34, 50 Among the other various secretions of paragangliomas, serotonin and its precursor, 5-hydroxytryptamine, are rarely associated with the clinical presentation of a carcinoid syndrome. 18, 34 The release of histamine and bradykinin during surgical manipulation can cause profound hypotension and even shock, with bronchial constriction that does not respond to conventional therapy. 34 
Malignant Paragangliomas
Malignant paragangliomas are seldom reported. Histological criteria do not predict the clinical behavior of paragangliomas, and their malignant potential is notoriously difficult to predict. Aside from overt metastasis, few if any microscopic features exist that allow the surgical pathologist to determine reliably whether a paraganglioma is benign or malignant. Hence, malignancy is determined more by a clinical course of rapid, aggressive growth, which is usually associated with anemia and the presence of metastasis. 7, 38 By 1980, there were 27 documented cases, 66 and a few additional ones have been reported since the paper by Zak and Lawson. 66 The natural history is usually one of rapid death, as can be seen in one of our patients. The most common sites of metastasis are in the neck, lymph nodes, and lung, but other visceral metastases have also been noted. 66 A review of the current literature shows recommendations for the use of electron microscopy and immunohistochemical studies with a panel of neuroendocrinological markers. 35 Clinically, malignant paragangliomas of a proven metastasis express considerably lower levels of neuropeptide. 38 The karyotyping used in our patient constitutes the first reported instance in which malignancy was determined through this method, but it did not show the abnormalities seen in the familial form, which is associated with the presence of the disease haplotype at chromosome band 11q23. 26, 48 Obviously, the prognosis for patients with malignant paragangliomas is extremely poor, and the effects of chemotherapy and radiation treatment have not been encouraging. 7 
Conclusions
Despite the challenges encountered in treating complex glomus jugulare tumors, resection is indicated and successful. Multiple tumors mandate a treatment plan that addresses the risk of bilateral cranial nerve deficits. The intrabulbar dissection technique can be used with any tumor as long as the tumor itself has not penetrated the wall of the jugular bulb or infiltrated the cranial nerves. Tumors that hypersecrete catecholamine require perioperative management and malignant tumors carry a poor prognosis.
